Conmed's Revenue in the fiscal year 2025 $ 1,374.72 millions
Conmed's Revenue in the fiscal year 2024 $ 1,307.02 millions
Conmed's Revenue in the fiscal year 2023 $ 1,244.74 millions
Conmed's Revenue in the fiscal year 2022 $ 1,045.47 millions
Conmed's Revenue in the fiscal year 2021 $ 1,010.64 millions
CNMD Revenue second quarter 2026 Y/Y Growth Comment
Conmed Corporation reported Revenue growth of 0.33% year on year in the second quarter 2026, to $ 343.49 millions, this is lower than Conmed Corporation's recent average Revenue growth of 4.82%.
Looking into second quarter 2026 results within Medical Equipment & Supplies industry 131 other companies have achieved higher Revenue growth. While Conmed Corporation' s Revenue increase of 0.33% ranks overall at the positon no. 2766 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Conmed's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
50.73 %
1.61 %
-26.27 %
(Sep 30 2020)
CNMD's II. Quarter Q/Q Revenue Comment
Conmed Corporation achieved in the II. Quarter 2026 above company average sequential Revenue increase of 8.34%, to $ 343.49 millions, from $317.05 millions in the first quarter. CNMD is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 35 other companies have achieved higher Revenue quarter on quarter growth. While Conmed's Revenue growth quarter on quarter, overall rank is 895.
Conmed Corporation achieved in the II. Quarter 2026 above company average sequential Revenue increase of 8.34%, to $ 343.49 millions, from $317.05 millions in the first quarter. CNMD is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 35 other companies have achieved higher Revenue quarter on quarter growth. While Conmed's Revenue growth quarter on quarter, overall rank is 895.
Conmed's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 1,371.66
$ 1,370.51
$ 1,374.72
$ 1,347.47
$ 1,326.25
Y / Y Revenue Growth (TTM)
3.42 %
4.14 %
5.18 %
4.61 %
3.94 %
Year on Year Revenue Growth Overall
Ranking
# 2064
# 1526
# 707
# 736
# 956
Seqeuential Revenue Change (TTM)
0.08 %
-0.31 %
2.02 %
1.6 %
0.78 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2393
# 1819
# 892
# 1397
# 1976
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Conmed's cumulative twelve months Revenue were $ 1,372 millions, company would post below average annual Revenue growth of 0.78% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Conmed's Revenue growth from the 317.05% growth in Mar 31 2026.
In the Healthcare sector 306 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1526 to 2064.
With the quarterly Revenue reported in the Jun 30 2026 period, Conmed's cumulative twelve months Revenue were $ 1,372 millions, company would post below average annual Revenue growth of -9.7% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Conmed's Revenue growth from the 317.05% growth in Mar 31 2026.
In the Healthcare sector 306 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1526 to 2064.
About Conmed Revenue Growth Rates (CNMD), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
0.33%